Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Public ClinicalTrials.gov record NCT07524946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Phase 4, Open-Label Study To Assess Safety, Pharmacokinetics, and Treatment Effect of CABTREO (Clindamycin Phosphate 1.2%, Adapalene 0.15%, and Benzoyl Peroxide 3.1%) Topical Gel In Pediatric Participants Ages 9 to 11 Years, 11 Month With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
Study identification
- NCT ID
- NCT07524946
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 9 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026
- Primary completion
- Nov 30, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Jul 28, 2026
2026 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Trial Associates | Bryant | Arkansas | 72002 | Recruiting |
| Northwest Arkansas Clinical Trials Center | Rogers | Arkansas | 72758 | Recruiting |
| Center for Dermatology Clinical Research | Freemont | California | 94538 | Recruiting |
| Ablon Skin Institute and Research Center | Manhattan Beach | California | 90266 | Recruiting |
| Ziaderm Research, LLC | North Miami Beach | Florida | 33162 | Recruiting |
| Clinical Research Trials of Florida, Inc | Tampa | Florida | 33607 | Recruiting |
| DS Research of Kentucky, LLC | Louisville | Kentucky | 40241 | Recruiting |
| Michigan Center for Skin Care Research | Clinton Township | Michigan | 48038 | Recruiting |
| JDR Dermatology Research | Las Vegas | Nevada | 89145 | Recruiting |
| DermResearchCenter of New York | Stony Brook | New York | 11790 | Recruiting |
| Vitality Clinical Trials, LLC | Woodbury | New York | 11797 | Recruiting |
| Flourish Research Acquisition, LLC | Apex | North Carolina | 70471 | Not yet recruiting |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | Recruiting |
| Cyn3rgy Research Corporation | Gresham | Oregon | 97030 | Recruiting |
| Breakaway Research Group | Spokane | Washington | 99202 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acne Vulgaris trials
Other public records listing Acne Vulgaris. Sorted by last update posted; newest first. Not a recommendation.
- NCT06225570: Weekly Isotretinoin vs Tetracycline for Moderate Acne Recruiting
- NCT05891795: Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy Active, not recruiting
- NCT07544251: Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne. Recruiting
- NCT02713607: Lipidome and Microbiome Profile of Acne Active, not recruiting
- NCT06425900: A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07524946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2026 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07524946 live on ClinicalTrials.gov.